MACKENZIE FINANCIAL CORP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$282,077
-16.1%
17,8530.0%0.00%
-100.0%
Q2 2023$336,172
+425.7%
17,853
+7.2%
0.00%
Q1 2023$63,948
-87.8%
16,653
-84.3%
0.00%
-100.0%
Q4 2022$525,279
+13.2%
105,903
+9.1%
0.00%0.0%
Q3 2022$464,000
+5.2%
97,035
-1.0%
0.00%0.0%
Q2 2022$441,000
+14.5%
98,037
+21.3%
0.00%0.0%
Q1 2022$385,000
-33.0%
80,816
+4.4%
0.00%0.0%
Q4 2021$575,000
+47.8%
77,446
+13.0%
0.00%0.0%
Q3 2021$389,000
-7.4%
68,530
+7.4%
0.00%0.0%
Q2 2021$420,000
-19.7%
63,796
-21.3%
0.00%0.0%
Q4 2020$523,00081,1100.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 10,477,879$37,720,0000.69%
QVT Financial LP 1,375,900$4,953,0000.60%
RA Capital Management 7,040,485$25,346,0000.46%
Birchview Capital, LP 380,000$1,368,0000.46%
XTX MARKETS LLC 18,861$68,0000.33%
Fernwood Investment Management, LLC 154,340$556,0000.26%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$375,0000.14%
Virtus ETF Advisers LLC 70,213$253,0000.13%
KENNEDY CAPITAL MANAGEMENT LLC 1,251,458$4,505,0000.13%
Assenagon Asset Management S.A. 4,987,334$17,954,0000.10%
View complete list of IMMUNOGEN INC shareholders